当前位置: 首页 > 期刊 > 《中华医学研究杂志》 > 2004年第11期
编号:10583359
高渗氯化钠羟乙基淀粉40溶液治疗出血性休克病人临床疗效分析
http://www.100md.com 《中华医学研究杂志》 2004年第11期
1资料与方法,2结果,3讨论,参考文献
     【摘要】 目的 为了评价4.2%高渗氯化钠羟乙基淀粉40治疗出血性休克病人的临床疗效。方法 选择均为创伤出血性休克病人。采取多中心临床试验、开放、前后自身对照方法。高渗氯化钠羟乙基淀粉40溶液8ml/min/kg静脉快速输注,给药后5~90min监测各时期血压、尿量、心率、肝肾功能。评价临床疗效标准:分别取邻近两次收缩压达到100~120mmHg时停止用药。结果 观察20例出血性休克病人,11例(55%)收缩压在给药后5min开始升高。7例(35%)在给药后10min血压开始升高。平均给药时间为(34.5±15.72)min,17例(85%)收缩压在用药后15~50min达到正常标准,P<0.01。输入高渗氯化钠羟乙基淀粉40平均剂量为(402.00±148.20)ml,施用药物后30min病人平均尿量为4.74ml/h/kg。结论 4.2%高渗氯化钠羟乙基淀粉40能够扩充血容量、提高血压、改善出血性休克病人的血流动力学。

    Teng Qingshan,Zhang Yuling,Chen Tao,et al.

    Department of Emergency,General Hospital of PLA,Beijing100853.

    【Abstract】 Objective To asses the clinical effect of a hypertonic sodium chloride hydroxylethy starch40(HSH)to treat the patients with hemorrhagic shock.Methods We choose the patients following a traumatic hemorˉrhagic shock.The clinical trial of a multiple center was taken on open,before and after themselves the control.8ml/min/kg body weight HSHwas infused by arapid intravenous injection,it was monitored by a various period time blood pressure,urinary output,heart rate,liver and renal function at times5-90minutes after given a drug.To asses the standard of the clinical therapeutic effect:the systolic blood pressure taken an adjoining two times was up to100-120mmHg stopping the drug.Results We observed20patients following hemorrhagic shock ......

您现在查看是摘要页,全文长 11196 字符